TUESDAY, March 1, 2016 (HealthDay News) — There’s just not enough good data to say whether or not seniors should be routinely screened for vision trouble by their primary care physicians, an influential panel of U.S. experts reports.
The U.S. Preventive Services Task Force (USPSTF) believes current data isn’t adequate to assess the potential benefits and harms of such screening in people 65 or older.
The task force is an independent, volunteer panel of experts that reviews the scientific evidence and makes recommendations on preventive health services.
“We need more evidence on accurate ways to screen for eye conditions in older adults in a primary care setting,” task force chair Dr. Al Siu said in a USPSTF news release. Siu is Mount Sinai Health System chair, and a professor in the department of geriatrics and palliative medicine at the Icahn School of Medicine at Mount Sinai, in New York City.
However, task force member Dr. Michael Pignone said that “older adults who are having vision problems should talk to their primary care doctor or eye specialist.”
Pignone, a professor of medicine at the University of North Carolina, said that “in the absence of clear evidence, primary care doctors should use their clinical judgment when deciding whether to screen for vision problems in patients without vision symptoms.”
Vision problems are a major impediment to seniors’ independence and quality of life. Common types of eye problems in older people include: refractive errors (the main reason people wear glasses or contacts); cataracts (clouding of the eye’s lens); and age-related macular degeneration (AMD), which affects vision in the center of the eye.
Primary care doctors typically check vision with an eye chart test. While this test can detect refractive errors, it does not identify early stage AMD or cataracts in people who do not report vision problems, according to the panel’s statement issued March 1.
One expert stressed, however, that checking seniors’ vision should be a top priority if symptoms arise.
“It remains clear that the elderly population is at risk for a number of sight-threatening diseases that can be treated, leading to better visual outcomes,” said Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital in New York City.
Pingback: vidalista 20 tadalafil tablets
Pingback: vidalista 60 mg tablets
Pingback: prilosec otc 10mg
Pingback: vardenafil chewables
Pingback: semaglutide injection for weight loss
Pingback: fincar side effects
Pingback: alli orlistat directions
Pingback: semaglutid naturlig i mat
Pingback: semaglutida comprimido efeitos colaterais
Pingback: semaglutid tabletten zum abnehmen erfahrungen
Pingback: doxycycline hyclate safe for dogs
Pingback: hims minoxidil review
Pingback: is acyclovir safe for toddlers
Pingback: toradol short term use reference
Pingback: minoxidil half‑life data
Pingback: sildenafil packaging integrity
Pingback: vardenafil 20 mg strength
Pingback: vardenafil 5 mg dose overview
Pingback: avanafil online safety protocol
Pingback: vardenafil’s vascular mechanism
Pingback: avanafil effect profile
Pingback: medical accuracy review
Pingback: Sildenafil Pharmacodynamics Resource
Pingback: Sildenafil Duration Explained
Pingback: Sildenafil vs Avanafil Absorption Speed
Pingback: how sildenafil is processed in the body
Pingback: what sildenafil is